Opinion: Specialists Back Single-Dose Vaccine Strategy for COVID-19 (includes Ruanne Barnabas)

Even partial protection of one dose could be enough to slow the spread of the virus, the UW Medicine researchers argue in a paper.

MEDIA CONTACT: Susan Gregg - 206.616.6730, sghanson@uw.edu

Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine.

UW Medicine starts Novavax COVID-19 vaccine clinical trial (includes Scott McClelland)

Volunteer enrollment begins for Phase III clinical trial that will determine the efficacy of Novavax vaccine candidate.

UW Medicine investigators are starting volunteer enrollment for an investigational COVID-19 vaccine clinical trial. The Phase III study will examine whether the Novavax vaccine candidate can protect against SARS-CoV-2, the coronavirus responsible for COVID-19.

How Safe and Effective Are the New Coronavirus Vaccines?

The U.S. Food and Drug Administration (FDA) has granted emergency use for two new coronavirus vaccines, one developed by the drug company Pfizer and the biotech company BioNTech and the other by the biotech company ModernaTX. Both are mRNA vaccines and have similar structure.

Both vaccines contain modified mRNA that provides the instructions for the synthesis of the SARS-CoV-2 spike glycoprotein antigen. Its mRNA is enveloped in lipid nanoparticles (LNPs) to prevent degradation and enhance uptake into cells.

No Country is Immune from Climate-Change Health Impacts (includes Jeremy Hess)

A global report and U.S. brief published in The Lancet show that further climate protections could save millions of lives.

Each year, The Lancet Countdown tracks more than 40 indicators on links between health and climate change. This year presents the most worrisom outlook to date as key trends worsen. The latest report finds that, with climate action, the lives of millions could be improved and saved.

Appreciation and Farewell for Joseph Babigumira, Associate Professor Global Health

Joseph Babigumira, MBChB, MS, PhD, has left his position as associate professor in the Department of Global Health, after nine years of service to his students, peer faculty and staff. Joseph has been an important contributor to the School of Public Health and the wider University of Washington community since he arrived in 2006 as a PhD student in the School of Pharmacy.  Over the years, he has touched many of us with his thoughtfulness, sincerity, quiet activism and dry wit – we will miss him greatly.

COVID-19: CDC Advisory Committee Hones in on Vaccine Rollout Recommendations (includes Beth Bell)

Jake EllisonUW News

When a vaccine to fight COVID-19 has been approved by the FDA for distribution, it’s unlikely that at first there will be enough doses for everyone. Consequently, the United States will need an equitable and effective plan for who gets those first doses, how they get them and who’s next.

Just as important, that plan — like the vaccine itself — has to be trusted and accepted by the general public.

Pages